Benzydamine/ Chlorhexidine
Indications
These indications are based on manufacturer information for both originator and generic products. For product specific registered indications, please refer to product specific manufacturer information
Registered South African indications:
- Mouth and throat infections and inflammation
Cautions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Benzydamine
Contraindications
- Hypersensitivity to the active ingredients or any of the excipients in this combination product
- Do not use in eye, auditory canal, or near meninges, spinal cord or brain
Cautions
- Breastfeeding
- Renal impairment
- Hepatic imapirment
- Elderly
- Preterm infants
Chlorhexidine
Contraindications
- Hypersensitivity to the active ingredients or any of the excipients in this combination product
Cautions
- Breastfeeding
- Avoid contact with eyes
Adult dosage
Forms avail. in SA and covered in this monograph: sol, spo
Relief of minor infections and inflammation in the mouth and throat
Benzydamine/ Chlorhexidine
22.5/18 (mg/15ml)
- Oral (sol): 15ml, 1.5-3hrly, gargle for 30secs, then expel from mouth; Max treatment duration: 7 days
- Oral (spo): 5-10 actuations, 1.5-3hrly, spray directly onto affected area, then gently swallow
Paediatric dosage
Paed. forms avail. in SA and covered in this monograph: sol
Relief of minor infections and inflammation in the mouth and throat
Benzydamine/ Chlorhexidine
22.5/18 (mg/15ml)
- Younger than 6 years: Not established for use
- Between 6-12 years: Oral (sol): 5-15ml, 3hrly, gargle for 30secs then expel from mouth; Max treatment duration: 7 days
- Older than 12 years: See adult dosage
Special populations
Recommendations for this combination product as per highest risk category when comparing individual active ingredients
Pregnancy
- Caution; not recommended (Benzydamine)
- Safety in pregnant women has not been established
Breastfeeding
- Caution; no information available
- Safety in breastfeeding has not been established
- It is not known if the components of this product is excreted in breast milk
- This product should not be used during breastfeeding unless considered essential by the physician
Renal Impairment
Hepatic Impairment
Elderly
Drugs in Sport
- Permitted - No warning
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Benzydamine
Central Nervous System Disorders
- Aguesia
- Dysguesia
- Glossodynia
- Oral paraesthesia
- Hypoasthesia
Gastrointestinal Disorders
- Tongue coated
- Dry mouth
- Discolouration of teeth and tongue
- Irritation of mouth
- Desquamation of oral mucosa
- Parotid gland swelling
Skin and Subcutaneous Tissue Disorders
- Allergic skin reactions
- Chemical burns in neonates
Immune, Blood and Lymphatic System Disorders
- Hypersensitivity reactions
- Anaphylaxis
Chlorhexidine
Respiratory Disorders
- Laryngospasm
- Bronchospasm
Gastrointestinal Disorders
- Oral numbness
- A stinging feeling in the mouth
Skin and Subcutaneous Tissue Disorders
- Hypersensitivity reactions
- Angioedema
Immune, Blood and Lymphatic System Disorders
- Anaphylaxis
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Benzydamine
- Anionic agents
- Tannins
- Organic matter
Chlorhexidine
- No information available
Monitoring
None routine
Mechanism of action
Benzydamine
An indazole non-steroidal anti-inflammatory drug (NSAID) with analgesic, antipyretic, and anti-oedema properties. Unlike other NSAIDs, benzydamine hydrochloride does not inhibit cyclooxygenases (COX) but stabilizes membranes, resulting in local anaesthesia and inhibits the production of pro-inflammatory cytokines
Chlorhexidine
Chlorhexidine is an antimicrobial whose affect is attributed to the attraction between chlorhexidine, a cation, and negatively charged bacterial cells. After chlorhexidine is absorpted onto the organism’s cell wall, it disrupts the integrity of the cell membrane and causes the leakage of intracellular components of the organisms
Dosage forms
- Mouthwash
- Spray
Formulation
COMBINATION PREPARATIONS
Benzydamine/ Chlorhexidine
Spray (per 15ml) 22.5mg/18mg
- Andolex C (iNova Pharma) originator
- Throflam Co (Pharmacare)
- Oranix (iNova)
Oral rinse (per 15ml) 22.5mg/18mg
- Andolex C (iNova Pharma) originator
- Throflam Co (Pharmacare)
- Oranix (iNova)
References
1. SAMF_12th Edition_Page 34 2. PI: Andolex - C oral rinse, iNova Pharmaceutical (Pty) Ltd:Date of registration: 2 Oct 2002 [https://drive.google.com/drive/u/0/folders/1aOnb7DkZDZE7InbAtNMWv2KnaOuMuTUQ] 3. https://www.medicines.org.uk/emc/product/529 (21/12/2016_GSK_Corsodyl 0.2% Mouthwash) 4. https://www.medicines.org.uk/emc/product/3348 (21/02/2017_Advanz_Oroeze Spray 0.15% w/v Oromucosal Spray) 5. https://www.medicines.org.uk/emc/product/3347 (12/12/2016_Advanz_Oroeze 0.15% w/v Mouthwash) 6. https://www.uptodate.com/contents/benzydamine-united-states-not-available-drug-information (date accessed: 11/01/2019) 7. https://www.uptodate.com/contents/chlorhexidine-gluconate-oral-drug-information (date accessed: 11/01/2019) 8. South African Institute for Drug-Free Sport; Andolex-C; Accessed online 11 Jan 2019 [http://www.drugfreesport.org.za/online-medication-check/]
Brands & products
9 products · cached snapshot- Andolex C
- Throflam Co
- Oranix
SPOSpray· 5 products
from R87.19| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Gesoral Oral Spray | 22.5 mg/15ml;mg/15ml | 30 | Pharma Dynamics (Pty) Ltd | R87.19 |
| Chlorzyd Antiseptic Throat Spray | 22.5 mg/15ml;mg/15ml | 30 | Unicorn Pharmaceuticals (Pty) Ltd | R87.19 |
| Oranix | 22.5 mg/15ml;mg/15ml | 30 | iNova Pharmaceuticals (Pty) Ltd | R99.08 |
| Throflam-Co | 22.5 mg/15ml;mg/15ml | 30 | Pharmacare Limited, Woodmead | R99.11 |
| Andolex-C Spray | 22.5 mg/15ml;mg/15ml | 30 | iNova Pharmaceuticals (Pty) Ltd | R115.27 |
MOWMouthwash· 4 products
from R102.03| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Chlorzyd Antiseptic Gargle | 22.5 mg/15ml;mg/15ml | 200 | Unicorn Pharmaceuticals (Pty) Ltd | R102.03 |
| Oranix | 22.5 mg/15ml;mg/15ml | 200 | iNova Pharmaceuticals (Pty) Ltd | R118.03 |
| Throflam-Co | 22.5 mg/15ml;mg/15ml | 200 | Pharmacare Limited, Woodmead | R118.06 |
| Andolex-C Oral Rinse | 22.5 mg/15ml;mg/15ml | 200 | iNova Pharmaceuticals (Pty) Ltd | R139.02 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.